The UCLA Foundation

  • Grantee Name: The UCLA Foundation
  • Project Description: to support preclinical and clinical trials studies to obtain FDA approval for the oral use of estriol in the treatment of relapsing remitting multiple sclerosis.
  • Grant Amount: $750000
  • Awarded Date: May, 2010
  • Project Start Date: July, 2010
  • Project End Date: June, 2013
  • Term (Months): 36
  • Area Served: USA
  • Related Priority: No
  • Website URL: http://www.uclafoundation.org